Project Grant F31MH138091

Award Date 12/24/24
Completion Date 7/31/27
Dollars Obligated $85K
Federal Grant Program
93.242
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21205, USA
Similar Awards
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) provides $2,507,054 to Synapticure Inc. to develop and validate a novel 3D in vitro platform for modeling genetic and sporadic frontotemporal dementia (FTD). The platform, called Cortical Brain Spheroids (CBS), utilizes patient-derived induced pluripotent stem cells to create 3D co-cultures that...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $251,250 to The Feinstein Institutes for Medical Research to study sex-dependent dysregulation of parvalbumin interneurons as a pathway to autism spectrum disorder (ASD). The key objectives are to: 1) Determine if the reduction in parvalbumin-expressing interneurons observed in male mice exposed in utero to anti-CASPR2 antibodies is associated with...
The Project Grant award R21NS142517, provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research aimed at identifying therapeutic targets for the treatment of tuberous sclerosis complex (TSC) and focal cortical dysplasia type II (FCDII). The $921,875 award to Yale University, spanning May 2025 to April 2027, will focus on studying the role of the...
This Project Grant award of $244,154, provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research at the Albert Einstein College of Medicine to investigate the regulation of presynaptic gene transcripts during synaptogenesis. The research, conducted over the period from September 1, 2024 to June 30, 2027, will leverage the genetic accessibility and...
This $169,500 Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants (CFDA 93.242) program supports research to identify the direct binding targets of the transcription factor FOXP1 in human cortical neural progenitor cells and neurons. The goal is to further the understanding of the disease mechanisms underlying FOXP1 syndrome, a rare neurodevelopmental disorder causing severe language and other impairments. The research will use...
Trustees of Tufts College, doing business as Tufts University School of Medicine, received a $453,750 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The funding will support research to define the potential of gene therapy to correct motor disabilities associated with CTNNB1 syndrome, a rare genetic disorder characterized by intellectual...
This federal Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $772,745 to the University of Southern California (USC) for a research project titled "Non-Synaptic Function of SYNGAP1 in Human Neurodevelopmental Disorders". The project aims to investigate the role of the SYNGAP1 gene in early brain development, particularly in human cortical progenitor cells and neurogenesis, to better...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants (CFDA 93.242) program, supports research to understand the role of the TBX1 gene in the development of cognitive deficits associated with neurodevelopmental disorders. The $289,119 award to the University of Texas Health Science Center at San Antonio will fund experiments using conditional TBX1 heterozygous mouse models to investigate the impact of TBX1 expression during the...
This Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) provides $253,500.00 to the Icahn School of Medicine at Mount Sinai to investigate the relationship between mitochondrial dysfunction and the impact of autism spectrum disorder-related risk genes on neuronal structure and function. The key objectives are to: 1) Resolve the relationship...
This federal Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $194,375 to the University of Wisconsin-Madison to characterize the impact of midbody remnant-mediated genetic information transfer on cortical development in autism spectrum disorder (ASD). The research aims to elucidate how an ASD-associated PTEN mutation alters the molecular composition of midbody remnants (MBRs) and how MBR uptake...

INVESTIGATING TCF4 AND SYNAPTIC DYSFUNCTION IN PITT-HOPKINS SYNDROME - PROJECT SUMMARY AUTISM SPECTRUM DISORDERS (ASDS) PRESENT A COMPLEX ARRAY OF NEURODEVELOPMENTAL CHALLENGES, AFFECTING APPROXIMATELY 1 IN 100 INDIVIDUALS GLOBALLY. DESPITE SUBSTANTIAL EFFORTS TO UNDERSTAND THE GENETIC UNDERPINNINGS OF ASD, THERAPEUTIC TREATMENTS REMAIN ELUSIVE. TRANSCRIPTION FACTOR 4 (TCF4) LOSS-OF-FUNCTION (LOF) MUTATIONS ARE IMPLICATED IN PITT-HOPKINS SYNDROME (PTHS), A SYNDROMIC FORM OF ASD. WHILE PTHS PATHOPHYSIOLOGY HAS BEEN EXTENSIVELY STUDIED IN MURINE MODELS, UNDERSTANDING TCF4 FUNCTION WITHIN A HUMAN CONTEXT IS IMPERATIVE. THIS PROPOSAL AIMS TO UTILIZE PATIENT-DERIVED INDUCED PLURIPOTENT CELLS (HIPSCS) TO MODEL SYNAPTIC TRANSMISSION, FOCUSING ON PRESYNAPTIC REGULATORY ROLES OF TCF4 AND THE THERAPEUTIC POTENTIAL OF RIMBP2 RE-EXPRESSION. OUR RECENTLY PUBLISHED DATA INDICATE SIGNIFICANT DEFICITS IN SPONTANEOUS EXCITATORY POSTSYNAPTIC CURRENTS (SEPSCS) AND NETWORK ACTIVITY IN PTHS HIPSC-DERIVED NEURONS, POTENTIALLY STEMMING FROM PRESYNAPTIC ABNORMALITIES. FROM OUR DIFFERENTIAL EXPRESSION GENE ANALYSIS, RIMBP2, A PRESYNAPTIC ORGANIZER, EMERGED AS THE MOST SIGNIFICANTLY DOWNREGULATED GENE, WITH ITS RE-EXPRESSION RESCUING DEFICITS IN NETWORK SYNCHRONICITY AND SEPSC FREQUENCY. IN THIS STUDY, I WILL EXPLORE THE IMPACT OF TCF4 LOF ON PRESYNAPTIC RELEASE, SUBCELLULAR PROTEIN LOCALIZATION, AND ULTRASTRUCTURE, ALONG WITH MECHANISM BY WHICH RIMBP2 RESCUES DEFICITS. IN AIM 1, I WILL EMPLOY LIVE-CELL IMAGING WITH THE GLUTAMATE SENSOR IGLUSNFR3 TO QUANTIFY PRESYNAPTIC RELEASE DEFICITS AND CHANGES IN EVOKED NEUROTRANSMITTER RELEASE, RELEASE PROBABILITY, AND COUPLING DISTANCE BETWEEN RELEASE READY VESICLES AND CALCIUM CHANNELS. ADDITIONALLY, WITH TIME-RESOLVED ELECTRON MICROSCOPY, I WILL EXAMINE DEFICITS IN SYNAPTIC ULTRASTRUCTURE. IN AIM 2, I WILL CHARACTERIZE DEFICITS INVOLVING CALCIUM CHANNEL CONDUCTANCE, EXPRESSION, AND LOCALIZATION. FIRST, I WILL MEASURE PRESYNAPTIC CALCIUM INFLUX WITH THE CALCIUM SENSOR SYNG-CAMP6F. THEN, USING QUANTITATIVE MICROSCOPY, I WILL ASSESS THE EXPRESSION AND LOCALIZATION OF CALCIUM CHANNELS ALONG WITH RELATED PROTEINS IN THE ACTIVE ZONE. FINALLY, I WILL EMPLOY LIVE-GOLD-LABELING ELECTRON MICROSCOPY TO MEASURE THE COUPLING DISTANCE BETWEEN CALCIUM CHANNELS AND DOCKED VESICLES AT THE NANOMETER SCALE. THE SIGNIFICANCE OF THIS RESEARCH LIES IN ELUCIDATING THE SYNAPTIC DEFICITS ASSOCIATED WITH TCF4 LOF, PROVIDING A FOUNDATION FOR TARGETED THERAPEUTICS. THE ANTICIPATED RESULTS COULD IDENTIFY CANDIDATE GENES AND INFORM NOVEL APPROACHES TO RESTORE PRESYNAPTIC RELEASE DEFICITS LINKED TO TCF4 DYSFUNCTION IN PTHS. THE STUDY'S INNOVATIVE METHODOLOGY, INCORPORATING ADVANCED IMAGING TECHNIQUES AND HUMAN-DERIVED MODELS, CONTRIBUTES A UNIQUE PERSPECTIVE TO UNDERSTANDING THE SYNAPTIC ARCHITECTURE OF NEURONS AFFECTED BY TCF4 MUTATIONS. WITH THE SUPPORT OF MY PROPOSED MENTORSHIP TEAM AND THE OUTSTANDING TRAINING ENVIRONMENT, THE RESEARCH AND TRAINING ACTIVITIES PROPOSED HERE WILL IDEALLY POSITION ME FOR A FUTURE CAREER IN ACADEMIC NEUROSCIENCE RESEARCH.

Posted 6/25/24, 12:00 AM